Abstract
The 2007 annual report of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) highlights an encouraging development in the reported numbers of newly diagnosed HIV infections among injecting drug users (IDUs) in the European Union (EU), but still very high levels of hepatitis C infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
